Synapse - Luis Diaz

Results (148)

Automated next-generation profiling of genomic alterations in human cancers

Journal Article

Keefer, L. A.; White, J. R.; Wood, D. E.; Gerding, K. M. R.; Valkenburg, K. C.; Riley, D.; Gault, C.; Papp, E.; Vollmer, C. M.; Greer, A.; more...
Nature Communications (2022)

Fulltext@MSK | Save

Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy – Authors' reply

Correspondence

André, T.; Diaz, L. A. Jr; Shiu, K. K.
Lancet Oncology (2022)

Fulltext@MSK | Save

PD-1 blockade in solid tumors with defects in polymerase epsilon

Journal Article

Rousseau, B.; Bieche, I.; Pasmant, E.; Hamzaoui, N.; Leulliot, N.; Michon, L.; de Reynies, A.; Attignon, V.; Foote, M. B.; Masliah-Planchon, J.; more...
Cancer Discovery (2022)

Fulltext@MSK | Save

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): Final analysis of a randomised, open-label, phase 3 study

Journal Article

Diaz, L. A. Jr; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Benavides, M.; Gibbs, P.; more...
Lancet Oncology (2022)

Fulltext@MSK | Save

Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study

Journal Article

Flory, A.; Kruglyak, K. M.; Tynan, J. A.; McLennan, L. M.; Rafalko, J. M.; Fiaux, P. C.; Hernandez, G. E.; Marass, F.; Nakashe, P.; Ruiz-Perez, C. A.; more...
PLoS ONE (2022)

Fulltext@MSK | Save

PD-1 blockade alone for mismatch repair deficient (dMMR) locally advanced rectal cancer

Meeting Abstract

Lumish, M. A.; Cohen, J. L.; Stadler, Z. K.; Weiss, J. A.; Lamendola-Essel, M. F.; Yaeger, R.; Segal, N. H.; El Dika, I. H.; Saltz, L. B.; Shcherba, M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A comprehensive comparison of early-onset and average-onset colorectal cancers

Journal Article

Cercek, A.; Chatila, W. K.; Yaeger, R.; Walch, H.; Dos Santos Fernandes, G.; Krishnan, A.; Palmaira, L.; Maio, A.; Kemel, Y.; Srinivasan, P.; more...
JNCI: Journal of the National Cancer Institute (2021)

Fulltext@MSK | Save

Final overall survival for the phase III KN177 study: Pembrolizumab versus chemotherapy in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC)